Loading...
Successful pregnancy in a patient with chronic myeloid leukaemia exposed to dasatinib during the first trimester
We report a case of a 25-year-old woman with chronic myeloid leukaemia who was randomised to dasatinib 100 mg orally daily in a clinical trial. The patient was advised to avoid pregnancy while on treatment due to its teratogenic potential. Five months later, the patient was found to be 6 weeks pregn...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3027573/ https://ncbi.nlm.nih.gov/pubmed/22791487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr.05.2010.2975 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|